Clinical Trial Update: Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial evaluating vismodegib as neoadjuvant therapy for basal cell carcinoma, sponsored by University Hospital Lille; the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

Sponsor: University Hospital, Lille | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED